Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morabito

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|October 7, 2024
pr-independent biogenesis of infectious mature Zika virus particlesKimberly A Dowd, Michelle Schroeder, Egan Sanchez, et al.
Frontiers in Immunology|December 27, 2021
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah VaccineRebecca J Loomis, Anthony T DiPiazza, Samantha Falcone, et al.
Bioconjugate Chemistry|September 2, 2016
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 AdjuvantJoseph R Francica, Geoffrey M Lynn, Richard Laga, et al.
Nature Communications|September 24, 2017
A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damageChao Shan, Antonio E Muruato, Brett W Jagger, et al.
Immunity|July 16, 2021
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challengeAnthony T DiPiazza, Sarah R Leist, Olubukola M Abiona, et al.
The Journal of Infectious Diseases|April 16, 2022
Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient PatientSjanna B Besteman, Emily Phung, Henriette H M Raeven, et al.
The Lancet. Respiratory Medicine|April 17, 2021
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trialTracy J Ruckwardt, Kaitlyn M Morabito, Emily Phung, et al.
Science Advances|August 22, 2020
Development of a potent Zika virus vaccine using self-amplifying messenger RNAKate Luisi, Kaitlyn M Morabito, Katherine E Burgomaster, et al.
Science Translational Medicine|December 20, 2019
DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomesKoen K A Van Rompay, Rebekah I Keesler, Amir Ardeshir, et al.
Science Translational Medicine|June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody qualitySonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|October 7, 2024
pr-independent biogenesis of infectious mature Zika virus particlesKimberly A Dowd, Michelle Schroeder, Egan Sanchez, et al.
Frontiers in Immunology|December 27, 2021
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah VaccineRebecca J Loomis, Anthony T DiPiazza, Samantha Falcone, et al.
Bioconjugate Chemistry|September 2, 2016
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 AdjuvantJoseph R Francica, Geoffrey M Lynn, Richard Laga, et al.
Nature Communications|September 24, 2017
A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damageChao Shan, Antonio E Muruato, Brett W Jagger, et al.
Immunity|July 16, 2021
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challengeAnthony T DiPiazza, Sarah R Leist, Olubukola M Abiona, et al.
The Journal of Infectious Diseases|April 16, 2022
Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient PatientSjanna B Besteman, Emily Phung, Henriette H M Raeven, et al.
The Lancet. Respiratory Medicine|April 17, 2021
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trialTracy J Ruckwardt, Kaitlyn M Morabito, Emily Phung, et al.
Science Advances|August 22, 2020
Development of a potent Zika virus vaccine using self-amplifying messenger RNAKate Luisi, Kaitlyn M Morabito, Katherine E Burgomaster, et al.
Science Translational Medicine|December 20, 2019
DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomesKoen K A Van Rompay, Rebekah I Keesler, Amir Ardeshir, et al.
Science Translational Medicine|June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody qualitySonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Pageof 9